title: Remission of acute monocytic leukemia, secondary to treatment with epipodophyllotoxins, in a patient with t(8;16)(p11;p13) and MYST3-CREBBP fusion.
authors.forename: José L
authors.initials: JL
authors.lastname: Vizmanos
authors.forename: María J
authors.initials: MJ
authors.lastname: Larráyoz
authors.forename: Iria
authors.initials: I
authors.lastname: Vázquez
authors.forename: María D
authors.initials: MD
authors.lastname: Odero
authors.forename: Roberto
authors.initials: R
authors.lastname: Hernández
authors.forename: Idoya
authors.initials: I
authors.lastname: Lahortiga
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Novo
authors.forename: María T
authors.initials: MT
authors.lastname: Ardanaz
authors.forename: María J
authors.initials: MJ
authors.lastname: Calasanz
mesh_terms: D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D016026:Bone Marrow Transplantation; D002871:Chromosome Banding; D002885:Chromosomes, Human, Pair 16 / Q000235:genetics*; D002898:Chromosomes, Human, Pair 8 / Q000235:genetics*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007621:Karyotyping; D007948:Leukemia, Monocytic, Acute / Q000139:chemically induced / Q000235:genetics / Q000628:therapy*; D008297:Male; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D011034:Podophyllotoxin / Q000009:adverse effects*; D012074:Remission Induction; D014178:Translocation, Genetic / Q000235:genetics*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; C470260:MOZ-CBP fusion protein, human; D015514:Oncogene Proteins, Fusion; D011034:Podophyllotoxin